Management of cutaneous side effects of EGFR inhibitors: recommendations from a German expert panel for the primary treating physician.

@article{Gutzmer2011ManagementOC,
  title={Management of cutaneous side effects of EGFR inhibitors: recommendations from a German expert panel for the primary treating physician.},
  author={Ralf Gutzmer and J{\"u}rgen C. Becker and Alexander Enk and Claus Garbe and Axel Hauschild and Martin Leverkus and Georg Reimer and Regina Treudler and A Tsianakas and Claas Ulrich and Andreas Wollenberg and Bernhard Homey},
  journal={Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG},
  year={2011},
  volume={9 3},
  pages={
          195-203
        }
}
  • Ralf Gutzmer, Jürgen C. Becker, +9 authors Bernhard Homey
  • Published in
    Journal der Deutschen…
    2011
  • Medicine
  • Inhibitors of the epidermal growth factor receptor (EGFR) are increasingly used in the treatment of various entities of malignant tumors. Patients treated with EGFR inhibitors very likely develop cutaneous side effects. The development of a papulopustular, follicular exanthema during the first weeks of therapy correlates with therapeutic benefit. However, this exanthema and other cutaneous side effects can impair the quality of life of the patient and might limit the therapy with the EGFR… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Topics from this paper.

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 16 CITATIONS

    Schattenseiten der Targeted Therapy

    VIEW 3 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Dermatological Toxicity Associated with Targeted Therapies in Cancer: Optimal Management

    VIEW 4 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients

    VIEW 7 EXCERPTS
    CITES BACKGROUND & RESULTS

    Neue Tyrosinkinase- und EGFR-Inhibitoren in der Tumortherapie

    VIEW 8 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Rare drug allergies: Review on prevalence and test procedures

    VIEW 1 EXCERPT
    CITES BACKGROUND

    Managing Cutaneous Side Effects From Targeted Molecular Inhibitors for Melanoma and Nonmelanoma Skin Cancer.

    • Nikki Tang, Désirée Ratner
    • Medicine
    • Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
    • 2016

    Skin problems and EGFR-tyrosine kinase inhibitor.